Project Grant D43TW012768
- This $2,305,547 Cooperative Agreement award was provided by the Centers for Disease Control and Prevention (CDC) under the Global AIDS Federal Grant Program (CFDA 93.067). The purpose of this project is to enable the Public Health Center (PHC) of the Ministry of Health of Ukraine to effectively leverage strategic information for evidence-based decision-making related to HIV/AIDS prevention and treatment programs. PATH, a global health nonprofit organization, will collaborate with the PHC to...
- This $302,142 Project Grant awarded by the Fogarty International Center (CFDA 93.989 - International Research and Research Training) aims to strengthen the capacity of researchers in Uganda to conduct HIV treatment and prevention clinical trials in perinatal, pediatric, adolescent, and at-risk populations, including women and their partners. The grant recipient, Mu-Jhu Care LTD, an international organization based in Kampala, Uganda, will establish a training center to offer short-term,...
- The Department of State Bureau of European and Eurasian Affairs awarded a $100,000 Project Grant to Medicinski Fakultet of Ukrayna to assess barriers to HIV prevention and treatment services that occurred due to the COVID-19 pandemic. The grant was awarded on July 2, 2021 under the General Department of State Assistance program (CFDA No. 19.700) to complete the assessment activities by May 31, 2022. The funding will support Medicinski Fakultet's evaluation of challenges to accessing HIV/AIDS...
- This Cooperative Agreement award of $520,059.00 from the Defense Health Agency under the Department of Defense HIV/AIDS Prevention Program (CFDA 12.350) is intended to extend the period of performance and add additional funding to the "Strategic Enhancement of HIV/AIDS Management within the Ukrainian Armed Forces" project. The awardee, Co 100 Percent Life, is a non-profit organization in Ukraine that specializes in public health interventions, particularly HIV/AIDS prevention and...
- This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $381,487 to the University of Maryland, Baltimore (UMB) to assess the early implementation of long-acting injectable cabotegravir (CAB-LA) pre-exposure prophylaxis (PrEP) among adolescent girls and young women (AGYW) at high risk of HIV acquisition in Zambia. The key objectives are to: 1) Evaluate implementation determinants of CAB-LA...
- The Department of Health and Human Services' Fogarty International Center has awarded a $303,316 Project Grant under the CFDA 93.989 International Research and Research Training program to Makerere University College of Health Sciences in Uganda. The grant, titled "Harnessing Health Data Science Capacity to Strengthen Evidence-Based Interventions, Policy and Response to the HIV/AIDS Epidemic in Uganda (H-DATA)", aims to train Ugandan scientists and healthcare practitioners in health...
- This Project Grant award, provided by the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), aims to investigate the impact of forced migration on HIV vulnerability and prevention among internally displaced adolescent girls and young women (AGYW) in Northern Mozambique. The funded project has two primary objectives: 1) to determine predictors of HIV vulnerability for this population, examining the relationship between exposure to...
- This Project Grant award in the amount of $431,712, funded by the National Institute of Allergy and Infectious Diseases under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to improve HIV testing among children under five in rural Uganda. The primary goal is to engage with traditional healers to facilitate HIV counseling and testing via oral swab antigen tests for this vulnerable pediatric population. The award supports two key activities: 1) determining barriers and...
- The Fogarty International Center (FIC), part of the National Institutes of Health (NIH), awarded a $268,665 project grant to the Joint Clinical Research Centre (JCRC) in Uganda under the International Research and Research Training program (CFDA 93.989). The grant, titled "Leveraging North-South Partnerships to Advance Cell and Gene Therapy for HIV Research Training Capacity in Uganda (C and GT-Uganda)," aims to strengthen research training capacity for cell and gene therapy approaches...
- This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $311,632 to Yale University to develop and implement a comprehensive fellowship program focused on HIV prevention and stigma reduction among men who have sex with men (MSM) in Malaysia. The key products and services to be delivered include: Identifying facilitators and barriers to implementing behavioral design interventions targeting HIV...
BUILDING CAPACITY IN HIV/TB AND MENTAL HEALTH IN UKRAINE'S HUMANITARIAN CRISIS - WE PROPOSE A MULTIDISCIPLINARY RESEARCH TRAINING MODEL BETWEEN BROWN UNIVERSITY (PROVIDENCE, RI), NATIONAL UNIVERSITY OF KYIV-MOHYLA ACADEMY ("NAUKMA;" UKRAINE), AND THE ALLIANCE FOR PUBLIC HEALTH ("ALLIANCE;" UKRAINE), IN CLOSE COLLABORATION WITH OUR CFAR PARTNERS AT BOSTON UNIVERSITY. THIS INITIATIVE WILL ENHANCE HIGH PRIORITY RESEARCH CAPACITY AIMING TO IMPROVE EQUITABLE ACCESS TO HIV CARE IN HUMANITARIAN SETTINGS IN UKRAINE. IT WILL TRAIN RESEARCHERS SUPPORTING HIGH QUALITY PREVENTION AND CARE ACROSS THE HIV CARE CONTINUUM IN CONFLICT AND POST-CONFLICT SETTINGS, INCLUDING THE CARE OF PERSONS COINFECTED WITH TUBERCULOSIS (TB) AND OTHER HIV COMORBIDITIES, INCLUDING SUBSTANCE USE DISORDERS (SUD) AND MENTAL HEALTH CONDITIONS. RUSSIA'S UNJUST WAR AGAINST UKRAINE HAS SEEN UNPRECEDENTED SYSTEMATIC ATTACKS AGAINST HEALTH WORKERS AND DEVASTATING DESTRUCTION OF MEDICAL FACILITIES, WHICH HAS DISRUPTED THESE PROCESSES. SIGNIFICANT RATES OF INTERNAL DISPLACEMENT, AFFECTING OVER 6 MILLION PEOPLE, HAVE DIMINISHED THE AVAILABILITY OF MEDICAL AND RESEARCH PERSONNEL, AS WELL AS DISRUPTED TREATMENT FOR PEOPLE WITH HIV (PWH). THIS IS SIGNIFICANT AS UKRAINE HAS AMONG THE HIGHEST BURDEN GLOBALLY OF HIV AND TB, INCLUDING MULTIDRUG-RESISTANT TB. EXPANDING CLINICAL INNOVATIONS IN HIV CARE (INCLUDING CARE FOR PEOPLE WITH HIV/TB COINFECTION AND OTHER COMORBIDITIES, SUCH AS SUD AND MENTAL HEALTH CONDITIONS) IS CRITICAL TO IMPROVE HEALTH OUTCOMES FOR INDIVIDUALS IN VOLATILE SETTINGS. OUR TRAINING COLLABORATION HAS POTENTIAL TO DEVELOP NEW MODELS FOR IMPLEMENTING THE HIV CARE CONTINUUM IN HUMANITARIAN CRISES. LESSONS LEARNED AND NEW MODELS FOR DIAGNOSIS AND MONITORING, LINKAGE, AND MAINTAINING CARE IN SETTINGS OF SEVERE HEALTH SYSTEMS DISRUPTIONS ARE OF ENORMOUS IMPORTANCE GLOBALLY. AIM #1: TO TRAIN A MULTIDISCIPLINARY COHORT OF UKRAINIAN RESEARCHERS WORKING ON THE HIV CARE CONTINUUM AND HIV COMORBIDITIES, INCLUDING TB, SUD, AND MENTAL HEALTH CONDITIONS, IN A CONFLICT-AFFECTED SETTING REDUCED MEDICAL INFRASTRUCTURE AND LARGE NUMBERS OF INTERNALLY DISPLACED PERSONS (IDPS). WE WILL RECRUIT AND TRAIN HIGHLY PROMISING UKRAINIAN SCHOLARS TO PURSUE ADVANCED DEGREES, CULMINATING IN AN HIV-FOCUSED THESIS (2 DOCTORAL AND 7 MASTERS). AIM #2: TO STRENGTHEN THE CAPACITY OF UKRAINIAN FACULTY AND RESEARCHERS TO CONDUCT RESEARCH IN HIV AND COMORBIDITIES, INCLUDING INNOVATIONS IN THE CARE CONTINUUM THAT ADDRESS HEALTH SYSTEMS DISRUPTION THE SPECIFIC NEEDS OF IDPS, THROUGH AN INNOVATIVE FACULTY FELLOWS TRAINING PROGRAM, WITH 6-MONTH TRAINING PROVIDED TO 3 UKRAINIAN FACULTY. THIS WILL ENCOMPASS CLINICAL, EPIDEMIOLOGIC, BEHAVIORAL, IMPLEMENTATION, AND LABORATORY RESEARCH WITH FUNDING AVAILABLE FOR SMALL HIV- FOCUSED PILOT PROJECTS AND POST-TRAINING MENTORING. AIM #3: TO ESTABLISH AN ANNUAL SYMPOSIUM FOR 20-30 PARTICIPANTS FOR FOCUSED RESEARCH FOR DISSEMINATION OF RESEARCH FINDINGS, NETWORKING, AND ENHANCING RESEARCH PROJECTS AND TO DEVELOP MORE INTENSIVE ONE-WEEK TRAINING WORKSHOPS IN COLLABORATION WITH OUR PARTNERS TO STRENGTHEN RESEARCH CAPACITY.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $50.0k | 7/28/25 |